144 related articles for article (PubMed ID: 30689078)
1. STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
Gong WJ; Ma LY; Hu L; Lv YN; Huang H; Xu JQ; Huang DD; Liu RJ; Han Y; Zhang Y; Shi SJ; Wu SL
Int J Clin Oncol; 2019 May; 24(5):476-484. PubMed ID: 30689078
[TBL] [Abstract][Full Text] [Related]
2. Association of CCND1 rs9344 polymorphism with lung cancer susceptibility and clinical outcomes: a case-control study.
Mei C; Wang T; Xu B; Wu S; Zhang X; Lv Y; Zhang Y; Liu Z; Gong W
BMC Pulm Med; 2024 Apr; 24(1):167. PubMed ID: 38589850
[TBL] [Abstract][Full Text] [Related]
3. Age-related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum-based chemotherapy.
Fang C; Li XP; Gong WJ; Wu NY; Tang J; Yin JY; Li X; Zhang W; Zhou HH; Liu ZQ
Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():21-29. PubMed ID: 27873337
[TBL] [Abstract][Full Text] [Related]
4. STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes.
Zhao L; Zhang Q; Luan X; Huang X; Zhao S; Zhao H
Int J Clin Exp Pathol; 2015; 8(2):2033-8. PubMed ID: 25973100
[TBL] [Abstract][Full Text] [Related]
5. Association between well-characterized lung cancer lncRNA polymorphisms and platinum-based chemotherapy toxicity in Chinese patients with lung cancer.
Gong WJ; Peng JB; Yin JY; Li XP; Zheng W; Xiao L; Tan LM; Xiao D; Chen YX; Li X; Zhou HH; Liu ZQ
Acta Pharmacol Sin; 2017 Apr; 38(4):581-590. PubMed ID: 28260796
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Long Non-Coding RNA CASC8 rs10505477 Polymorphism in Lung Cancer Susceptibility, Platinum-Based Chemotherapy Response, and Toxicity.
Hu L; Chen SH; Lv QL; Sun B; Qu Q; Qin CZ; Fan L; Guo Y; Cheng L; Zhou HH
Int J Environ Res Public Health; 2016 May; 13(6):. PubMed ID: 27249003
[TBL] [Abstract][Full Text] [Related]
7. Association of Wnt-Inducible Signaling Pathway Protein 1 Genetic Polymorphisms With Lung Cancer Susceptibility and Platinum-Based Chemotherapy Response.
Chen J; Yin JY; Li XP; Wang Y; Zheng Y; Qian CY; He H; Fang C; Wang Z; Zhang Y; Xiao L; Wang SY; Zhang W; Zhou HH; Liu ZQ
Clin Lung Cancer; 2015 Jul; 16(4):298-304.e1-2. PubMed ID: 25656821
[TBL] [Abstract][Full Text] [Related]
8. [Correlations between genetic variations of glutathione synthetase gene and the response to platinum-based chemotherapy and prognosis of small cell lung cancer patients].
Feng T; Li HM; Yuan P; Yu DK; Ma F; Tan WW; Du ZL; Yang J; Huang Y; Lin DX; Xu BH; Tan W
Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):115-120. PubMed ID: 28219206
[No Abstract] [Full Text] [Related]
9. Genetic variants of GADD45A, GADD45B and MAPK14 predict platinum-based chemotherapy-induced toxicities in Chinese patients with non-small cell lung cancer.
Jia M; Zhu M; Wang M; Sun M; Qian J; Ding F; Chang J; Wei Q
Oncotarget; 2016 May; 7(18):25291-303. PubMed ID: 26993769
[TBL] [Abstract][Full Text] [Related]
10. Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.
Qian J; Qu HQ; Yang L; Yin M; Wang Q; Gu S; Wu Q; Zhao X; Wu W; Wu J; Tan X; Chen W; Wang H; Wang J; Fan W; Chen H; Han B; Lu D; Wei Q; Jin L
Oncologist; 2012; 17(12):1551-61. PubMed ID: 22843554
[TBL] [Abstract][Full Text] [Related]
11. [Genetic variation in DNA polymerase kappa gene is associated with the prognosis after platinum-based chemotherapy in small cell lung cancer patients].
Chen JN; Feng T; Yang J; Li HM; Yuan P; Ma F; Yin LL; Lin DX; Xu BH; Tan W
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):112-117. PubMed ID: 30862140
[No Abstract] [Full Text] [Related]
12. Associations of genetic polymorphisms of the transporters organic cation transporter 2 (OCT2), multidrug and toxin extrusion 1 (MATE1), and ATP-binding cassette subfamily C member 2 (ABCC2) with platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients.
Qian CY; Zheng Y; Wang Y; Chen J; Liu JY; Zhou HH; Yin JY; Liu ZQ
Chin J Cancer; 2016 Sep; 35(1):85. PubMed ID: 27590272
[TBL] [Abstract][Full Text] [Related]
13. Novel association between CD74 polymorphisms and hematologic toxicity in patients with NSCLC after platinum-based chemotherapy.
Tan X; Wu Q; Cai Y; Zhao X; Wang S; Gao Z; Yang Y; Li X; Qian J; Wang J; Su B; Chen H; Han B; Jiang G; Lu D
Clin Lung Cancer; 2014 Jan; 15(1):67-78.e12. PubMed ID: 24220096
[TBL] [Abstract][Full Text] [Related]
14. STAT3 genetic variant, alone and in combination with STAT5b polymorphism, contributes to breast cancer risk and clinical outcomes.
Zhao H; Wang Z; Wu H; Xiao Q; Yao W; Wang E; Liu Y; Wei M
Med Oncol; 2015 Jan; 32(1):375. PubMed ID: 25487443
[TBL] [Abstract][Full Text] [Related]
15. Association between STAT3 gene polymorphisms and Crohn's disease susceptibility: a case-control study in a Chinese Han population.
Wang Z; Xu B; Zhang H; Fan R; Zhou J; Zhong J
Diagn Pathol; 2014 May; 9():104. PubMed ID: 24885273
[TBL] [Abstract][Full Text] [Related]
16.
Li YQ; Zhang XY; Chen J; Yin JY; Li XP
J Cancer Res Ther; 2018; 14(4):881-886. PubMed ID: 29970670
[TBL] [Abstract][Full Text] [Related]
17. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
Gong WJ; Yin JY; Li XP; Fang C; Xiao D; Zhang W; Zhou HH; Li X; Liu ZQ
Tumour Biol; 2016 Jun; 37(6):8349-58. PubMed ID: 26729200
[TBL] [Abstract][Full Text] [Related]
18. Association of signal transducer and activator of transcription 3 gene polymorphisms with cervical cancer in Chinese women.
Wang K; Zhou B; Zhang J; Xin Y; Lai T; Wang Y; Hou Q; Song Y; Chen Y; Quan Y; Xi M; Zhang L
DNA Cell Biol; 2011 Nov; 30(11):931-6. PubMed ID: 21668356
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymorphisms in XPD on clinical outcomes of platinum-based chemotherapy for Chinese non-small cell lung cancer patients.
Wu W; Li H; Wang H; Zhao X; Gao Z; Qiao R; Zhang W; Qian J; Wang J; Chen H; Wei Q; Han B; Lu D
PLoS One; 2012; 7(3):e33200. PubMed ID: 22479369
[TBL] [Abstract][Full Text] [Related]
20. XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
Lawania S; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
